Advagene Biopharma Co., Ltd. 6709.TWO Stock
18.2 TWD
{{ price }}
-4.712040%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Taiwan
Exchange
Taipei Exchange
Market Cap
971.52M TWD
LOW - HIGH [24H]
18.2
-
19.05 TWD
VOLUME [24H]
48K TWD
{{ volume }}
P/E Ratio
0
Earnings per share
-1.83 TWD
Advagene Biopharma Co., Ltd. Price Chart
Advagene Biopharma Co., Ltd. 6709.TWO Financial and Trading Overview
| Advagene Biopharma Co., Ltd. stock price | 18.2 TWD |
| Previous Close | 29.1 TWD |
| Open | 28.6 TWD |
| Bid | 29.05 TWD x 0 |
| Ask | 29.45 TWD x 0 |
| Day's Range | 28.5 - 29.6 TWD |
| 52 Week Range | 26.9 - 45.2 TWD |
| Volume | 69.2K TWD |
| Avg. Volume | 46.04K TWD |
| Market Cap | 1.44B TWD |
| Beta (5Y Monthly) | 0.733643 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.83 TWD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
6709.TWO Valuation Measures
| Enterprise Value | 1.34B TWD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 10.898876 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -11.584 |
Trading Information
Advagene Biopharma Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.733643 |
| 52-Week Change | -17.045% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 45.2 TWD |
| 52 Week Low | 26.9 TWD |
| 50-Day Moving Average | 29.8 TWD |
| 200-Day Moving Average | 32.1 TWD |
6709.TWO Share Statistics
| Avg. Volume (3 month) | 46.04K TWD |
| Avg. Daily Volume (10-Days) | 53.99K TWD |
| Shares Outstanding | 49.35M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -37.32% |
| Return on Equity (ttm) | -62.085% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -115248000 TWD |
| Net Income Avi to Common (ttm) | -118377000 TWD |
| Diluted EPS (ttm) | -2.37 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 103.01M TWD |
| Total Cash Per Share (mrq) | 2.09 TWD |
| Total Debt (mrq) | 2.01M TWD |
| Total Debt/Equity (mrq) | 1.52 TWD |
| Current Ratio (mrq) | 14.937 |
| Book Value Per Share (mrq) | 2.67 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -109352000 TWD |
| Levered Free Cash Flow (ttm) | -76118872 TWD |
Profile of Advagene Biopharma Co., Ltd.
| Country | Taiwan |
| State | N/A |
| City | Taipei |
| Address | No. 308, Neihu Road |
| ZIP | 114 |
| Phone | 886 2 2797 0073 |
| Website | https://www.advagene.com.tw |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 12 |
Advagene Biopharma Co., Ltd. engages in the research and development of vaccine technology and related products in Taiwan. Its products in development include nasal spray influenza vaccine, allergy vaccines, and COVID-19 immunotherapy. The company is based in Taipei, Taiwan.
Q&A For Advagene Biopharma Co., Ltd. Stock
What is a current 6709.TWO stock price?
Advagene Biopharma Co., Ltd. 6709.TWO stock price today per share is 18.2 TWD.
How to purchase Advagene Biopharma Co., Ltd. stock?
You can buy 6709.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Advagene Biopharma Co., Ltd.?
The stock symbol or ticker of Advagene Biopharma Co., Ltd. is 6709.TWO.
Which industry does the Advagene Biopharma Co., Ltd. company belong to?
The Advagene Biopharma Co., Ltd. industry is Biotechnology.
How many shares does Advagene Biopharma Co., Ltd. have in circulation?
The max supply of Advagene Biopharma Co., Ltd. shares is 53.38M.
What is Advagene Biopharma Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Advagene Biopharma Co., Ltd. PE Ratio is now.
What was Advagene Biopharma Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Advagene Biopharma Co., Ltd. EPS is -1.83 TWD over the trailing 12 months.
Which sector does the Advagene Biopharma Co., Ltd. company belong to?
The Advagene Biopharma Co., Ltd. sector is Healthcare.